Disordered cellular immunity in type 1 diabetes of man and the BB rat

  • John B. Buse
  • Richard F. Rowley
  • George S. Eisenbarth


Beta Cell Bete Spontaneous Diabetes Suppressor Cell Activity Streptozotocin Induce Diabetes Mellitus 


  1. 1.
    Rotter, J.I.; Rimoin, D.L.: Genetics; in Brownlee, Diabetes mellitus, vol. 1: etiology, hormone physiology, pp. 3–93 (Garland, New York 1981).Google Scholar
  2. 2.
    Volpe, R.: Monographs on endocrinology, vol. 20: Autoimmunity in the endocrine system (Springer, New York 1981).Google Scholar
  3. 3.
    Kahn, C.R.; Baird, K.L.; Flier, J.S.; Grunfeld, C.; Harmon, J.T.; Harrison, L.C.; Karlsson, F.A.; Kasuga, M.; King, G.L.; Lang, U.C.; Podskalny, J.M.; Obberghen, E.V.: Insulin receptors, receptor antibodies and the mechanism of insulin action. Recent Prog. Horm. Res.37: 477–533 (1981).PubMedGoogle Scholar
  4. 4.
    Cahill, G.F., Jr.; McDevitt, H.O.: Insulin-dependent diabetes mellitus: the initial lesion. New Engl. J. Med.304: 1454–1465 (1981).PubMedGoogle Scholar
  5. 5.
    Handwerger, B.S.; Fernandes, G.; Brown, D.M.: Immune and autoimmune aspects of diabetes mellitus. Human Pathol.11: 338–352 (1980).CrossRefGoogle Scholar
  6. 6.
    Selam, J.L.; Clot, J.; Andary, M.; Mirouze, J.: Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Diabetologia16: 35–40 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    Ptak, W.; Hanczakowska, M.; Rozycka, R.; Rozycka, D.: Impaired antibody responses in alloxan diabetic mice. Clin. exp. Immunol.29: 140–146 (1977).PubMedGoogle Scholar
  8. 8.
    Ptak, W.; Rewicka, M.; Kollat, M.: Development of specific suppressor cells in hypoinsulinaemic mice. Nature283: 199–200 (1980).PubMedCrossRefGoogle Scholar
  9. 9.
    Ptak, W.; Rewicka, M.; Kollat, M.; Walicki, W.: Ease of induction of cells producing TNP-specific suppressor factor in hypoinsulinemic mice. Clin. Immunol. Immunopathol.19: 447–451 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    Roth, M.D.; Barg, M.; Michalski, R.; Arquilla, E.R.: Cell-mediated immunity in chronically diabetic mice. Diabetes29: 825–829 (1980).PubMedGoogle Scholar
  11. 11.
    Bersani, G.; Zanco, P.; Padovan, D.; Betterle, C.: Lymphocyte subpopulations in insulin-dependent diabetics with and without serum islet-cell autoan-tibodies. Diabetologia20: 47–50 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    Jackson, R.; Rassi, N.; Crump, T.; Haynes, B.; Eisenbarth, G.S.: The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes30: 887–889 (1981).PubMedCrossRefGoogle Scholar
  13. 13.
    Poussier, P.; Nakhooda, A.F.; Falk, J.A.; Lee, C; Marliss, E.B.: Lymphopenia and abnormal lymphocyte subsets in the ‘BB’ rat: relationship to the diabetic syndrome. Endocrinology110: 1825–1827 (1982).PubMedGoogle Scholar
  14. 14.
    Elder, M.; MacLaren, N.: Immunoincompetence in the BB rat (Abstract). Diabetes31: suppl. 2, p. 48 (1982).Google Scholar
  15. 15.
    Nakhooda, A.F.; Like, A.A.; Chappel, C.I.; Murray, F.T.; Marliss, E.B.: The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes26: 100–112 (1976).CrossRefGoogle Scholar
  16. 16.
    Like, A.A.; Butler, L.; Williams, R.M.; Appel, M.C.; Weringer, E.J.; Rossini, A.A.: Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes31: suppl. 1. pp. 7–13 (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    Marliss, E.B.; Sima, A.A.F.; Nakhooda, A.F.: Spontaneous diabetes in the ‘BB’ Wistar rat; in Martin, Ehrlich, Holland, Etiology and pathogenesis of insulin dependent diabetes mellitus, pp. 251–274 (Raven Press, New York 1981).Google Scholar
  18. 18.
    Tannenbaum, G.S.; Colle, E.; Gurd, W.; Wana-maker, L.: Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. I. Longitu- dinal profiles of plasma growth hormone, insulin, and glucose. Endocrinology109: 1872–1879 (1981).PubMedGoogle Scholar
  19. 19.
    Tannenbaum, G.S.; Colle, E.; Wanamaker, L.; Gurd, W.; Goldman, H.; Seemayer, T.A.: Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. II. Insulin-, glucagon-, and somatostatin-reactive cells in the pancreas. Endocrinology109: 1880–1887 (1981).PubMedCrossRefGoogle Scholar
  20. 20.
    Nakhooda, A.F.; Like, A.A.; Chappel, C.I.; Wei, C.-N.; Marliss, E.B.: The spontaneously diabetic Wistar rat (the ‘BB’ rat). Studies prior to and during development of the overt syndrome. Diabetologia14: 199–207 (1978).PubMedCrossRefGoogle Scholar
  21. 21.
    Rossini, A.A.; Williams, R.M.; Mordes, J.P.; Appel, M.C.; Like, A.A.: Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes28: 1031–1032 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    Rossini, A.A.; Mordes, J.P.; Williams, R.M.; Like, A.A.: Expression of diabetes in Bio-Breeding/Worcester (BB/W) rats is not influenced by diet (Abstract). Diabetes30: suppl. 1, p. 93 (1981).Google Scholar
  23. 23.
    Elder, M.; McLaren, N.; Riley, W.; McConnell, T.: Gastric parietal cell and other autoantibodies in the BB rat. Diabetes31: 313–318 (1982).PubMedCrossRefGoogle Scholar
  24. 24.
    Sternthal, E.; Like, A.A.; Sarantis, K.; Braverman, L.E.: Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes30: 1058–1061 (1981).PubMedCrossRefGoogle Scholar
  25. 25.
    Eisenbarth, G.; Jackson, R.: Immunogenetics of polyglandular failure and related disease; in Farid, HLA in endocrine and metabolic disorders (Academic Press, New York 1981).Google Scholar
  26. 26.
    Dobersen, M.J.: Humoral autoimmunity in insulin-dependent (type I) diabetes mellitus. A current assessment. Surv. immunol. Res.1: 329–338 (1982).PubMedGoogle Scholar
  27. 27.
    Dyrberg, T.; Nakhooda, A.F.; Baekkeskov, S.; Lernmark, A.; Poussier, P.; Marliss, E.B.: Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes31: 278–281 (1982).PubMedCrossRefGoogle Scholar
  28. 28.
    Dyrberg, T.; Nakhooda, A.F.; Baekkeskov, S.; Poussier, P.; Marliss, E.B.; Lernmark, A.: Islet cell surface antibodies (ICSA) and lymphocyte antibodies (LA) in the spontaneously diabetic BB Wistar rat (Abstract). Diabetes31: suppl. 2, p. 19 (1982).Google Scholar
  29. 29.
    Naji, A.; Silvers, W.; Bellgrau, D.; Barker, C.: Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science213: 1390–1392 (1981).PubMedCrossRefGoogle Scholar
  30. 30.
    Like. A.; Rossini, A.; Guberski, D.; Appel, M.: Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science206: 1421–1423 (1979).PubMedCrossRefGoogle Scholar
  31. 31.
    Like, A.; Kislauskis, E.; Williams, R.; Rossini, A.: Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science216: 644–646(1982).PubMedCrossRefGoogle Scholar
  32. 32.
    Naji, A.; Silvers, W.K.; Barker, C.F.: Islet transplantation in spontaneously diabetic rats. Transplant. Proc.13: 826–828 (1981).PubMedGoogle Scholar
  33. 33.
    Kadison, P.: Jackson, R.; Rassi, N.; Haynes, B.; Jegasothy, B.; Eisenbarth, G.S.: The BB rat: selective W3/25 T cell lymphocytopenia and profound depression of mitogen responsiveness (Abstract). Clin. Res.30: 396 (1982).Google Scholar
  34. 34.
    Jackson, R.: Buse, J.B.; Eisenbarth, G.S.: Unpublished observations.Google Scholar
  35. 35.
    Haynes, B.: Warren, R.; Buckley, R.; McClure, J.; Goldstein, A.; Eisenbarth, G.S.: Complex ganglio-sides as markers of thymic epithelium: demonstration of defects in thymic epithelium structure and ganglioside expression in severe combined immunodeficiency disease (Abstract). Clin. Res.30: 350 (1982).Google Scholar
  36. 36.
    Colle, E.; Guttmann, R.D.; Seemayer, T.: Spontaneous diabetes mellitus syndrome in the rat. J. exp. Med.154: 1237–1242 (1981).PubMedCrossRefGoogle Scholar
  37. 37.
    Colle, E.; Guttmann, R.D.; Michel, F.; Seemayer, T.A.: Genetics of T lymphopenia in the syndrome of spontaneous diabetes mellitus in the rat (Abstract). Diabetes31: suppl. 2, p. 46 (1982).Google Scholar
  38. 38.
    LeCompte, P.M.: ‘Tnsulitis’ in early juvenile diabetes. Archs Path.66: 450–457 (1958).Google Scholar
  39. 39.
    Gepts, W.: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes14: 619–633 (1965).PubMedGoogle Scholar
  40. 40.
    Eisenbarth, G.S.; Wilson, P.W.; Ward, F.; Buckley, C; Lebovitz. H.: The polyglandular failure syndrome: disease inheritance, HLA type, and immune function. Ann. intern. Med.91: 528–533 (1979).PubMedGoogle Scholar
  41. 41.
    Nerup, J.; Andersen, O.O.; Bendixen, G.; Egeberg, J.; Poulsen, J.E.: Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes20: 424–427 (1971).PubMedGoogle Scholar
  42. 42.
    Nerup, J.; Andersen, O.O.; Bendixen, G.; Egeberg, J.; Poulsen, J.E.; Anti-pancreatic, cellular hyper- sensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta allerg.28: 223–230 (1973).Google Scholar
  43. 43.
    MacCuish, A.C.; Jordan, J.; Campbell, C.J.; Duncan, L.J.P.; Irvine, W.J.: Cell-mediated immunity to human pancreas in diabetes mellitus. Diabetes25:693–697(1974).Google Scholar
  44. 44.
    Nagaoka, K.; Sakurami, T.; Nabeya, N.; Imura, H.; Kuno, S.: The leucocyte migration inhibition test and subpopulations of peripheral lymphocytes in insulin-dependent diabetics. Endocr. jap.26: 89–95(1979).Google Scholar
  45. 45.
    Irvine, W.J.; MacCuish, A.C.; Campbell, C.J.; Duncan, L.J.P.: Organ-specific cell-mediated autoimmunity in diabetes mellitus. Acta endocr., suppl. 205, pp. 65–75 (1976).Google Scholar
  46. 46.
    Huang, S.-W.; MacLaren, N.K.: Insulin-dependent diabetes: a disease of autoaggression. Science192:64–66 (1976).PubMedCrossRefGoogle Scholar
  47. 47.
    Scott, J.; Daniels, J.C.; Poffenbarger, P.L.: In vitro cell-mediated cytolysis of intact islets of Langerhans in a study of type I diabetics (Abstract). Diabetologia21: 78–79 (1981).CrossRefGoogle Scholar
  48. 48.
    Boitard, C; Debray-Sachs, M.; Pouplard, A.; Assan, R.; Hamburger, J.: Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia21:41–46 (1981).PubMedGoogle Scholar
  49. 49.
    Kaldany, A.; Hill, T.; Wentworth, S.; Brink, S.J.; Delia, J.A.; Clouse, M.; Soeldner, J.S.: Trapping of peripheral blood lymphocytes in the pancreas of patients with acute-onset insulin-dependent diabetes mellitus. Diabetes31: 463–466 (1982).PubMedCrossRefGoogle Scholar
  50. 50.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Passive transfer of diabetes mellitus from man to mouse. Lanceti: 908–910 (1978).CrossRefGoogle Scholar
  51. 51.
    Neufeld, M.; McLaughlin, J.; MacLaren, N.K.; Rosenbloon, E.; Donnelly, W.: Failure to transfer diabetes mellitus from man to mouse. New Engl. J. Med.301: 665 (1979).PubMedGoogle Scholar
  52. 52.
    Lipsick, J.; Beattie, G.; Osier, A.G.; Kaplan, N.O.: Letter to the editor. Lanceti: 1290–1291 (1979).CrossRefGoogle Scholar
  53. 53.
    Thurneyssen, O.; Jansen, F.K.; Vialettes, B.; Vague, P.; Selam, J.L.; Mirouze, J.: Letter to the editor. Lanceti: 1291–1292 (1979).Google Scholar
  54. 54.
    Serra, A.S.; Farndon, J.R.; Shenton, B.K.; Johnston, I.D.A.: Letter to the editor. Lanceti: 1292 (1979).Google Scholar
  55. 55.
    Buschard, K.; Rygaard, J.; Madsbad, S.: Letter to the editor. Lancetii: 303 (1979).CrossRefGoogle Scholar
  56. 56.
    Beattie, G.; Lannom, R.; Lipsick, J.; Kaplan, N.O.; Osier, A.G.: Streptozotocin-induced diabetes in athymic and conventional BALB/c mice. Diabetes29: 146–150 (1980).PubMedCrossRefGoogle Scholar
  57. 57.
    Buschard, K.; Rygaard, J.: Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Acta pathol. microbiol. scand., C, Immunol.85: 469–472 (1977).Google Scholar
  58. 58.
    Kiesel, U.; Freytag, G.; Biener, J.; Kolb, H.: Transfer of experimental autoimmune insulitis by spleen cells in mice. Diabetologia19: 516–520 (1980).PubMedCrossRefGoogle Scholar
  59. 59.
    Paik, S.-G.; Fleischer, N.; Shin, S.-L.: Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc. natn. Acad. Sci. USA77: 6129–6133 (1980).CrossRefGoogle Scholar
  60. 60.
    Buschard. K.; Rygaard, J.: T-lymphocytes transfer streptozotocin induced diabetes mellitus in mice. Acta pathol. microbiol. scand., C, Immunol.86: 277–282 (1978).Google Scholar
  61. 61.
    Rossini. A.A.; Williams, R.M.; Appel, M.C.; Like, A.A.: Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature276: 182–184 (1978).PubMedCrossRefGoogle Scholar
  62. 62.
    Buschard, K.; Rygaard, J.; Lund, E.: The inability of a diabetogenic virus to induce diabetes mellitus in athymic (nude) mice. Acta pathol. microbiol. scand.. C Immunol.84: 299–303 (1976).Google Scholar
  63. 63.
    Paik, S.-G.; Yoon, J.-W.; Shin, S.: Induction of diabetes in mice by EMC virus: host T cells are not required (Abstract). Diabetes31: suppl. 2, p. 66 (1982).Google Scholar
  64. 64.
    Jansen. F.K.: Muntefering, H.; Schmidt, W.A.K.: Virus induced diabetes and the immune system. Diabetologia13: 545–549 (1977).PubMedCrossRefGoogle Scholar
  65. 65.
    Onodera, T.; Ray, U.R.; Melez, K.A.; Suzuki, H.; Toniolo, A.; Notkins, A.L.: Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature297:66–68 (1982).PubMedCrossRefGoogle Scholar
  66. 66.
    Ambinder, J.M.; Chiorazzi, N.; Gibofsky, A.; Fotino, M.; Kunkel. H.G.: Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin. Immunol. Immunopathol.23: 269–274 (1982).PubMedCrossRefGoogle Scholar
  67. 67.
    Jackson, R.A.; Morris, M.A.; Haynes, B.F.; Eisen-barth, G.S.: Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. New Engl. J. Med.306: 785–788 (1982).PubMedGoogle Scholar
  68. 68.
    Pozzilli, P.: Sensi, M.; Gorsuch, A.; Bottazzo, G.F.; Cudworth, A.G.: Evidence for raised K-cell levels in type I diabetes. Lancetii: 173–175 (1979).CrossRefGoogle Scholar
  69. 69.
    Pozzilli, P.; Sensi, M.; Dean, B.; Gorsuch, A.; Cudworth, A.: The importance of measuring Fc+ (killer) cells in insulin-dependent (type I) diabetes. Acta diabet. lat.17: 119–122 (1980).CrossRefGoogle Scholar
  70. 70.
    Sensi, M; Pozzilli, P.; Gorsuch, A.N.; Bottazzo, G.F.; Cudworth, A.G.: Increased killer cell activity in insulin dependent (type I) diabetes mellitus. Diabetologia20: 106–109 (1981).PubMedCrossRefGoogle Scholar
  71. 71.
    Sensi, M.; Pozzilli, P.; Cudworth, A.G.: Antibody-dependent and natural killer cytotoxicity in type I diabetes. Acta diabet. lat.18: 339–344 (1981).CrossRefGoogle Scholar
  72. 72.
    Ludwig, H.; Schernthaner, G.; Kraft, D.; Scheiner, O.; Mayr, W.R.: Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus. J. endocrinol. Invest.3: 39–44 (1980).PubMedGoogle Scholar
  73. 73.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin. exp. Immunol.41: 25–32 (1980).PubMedGoogle Scholar
  74. 74.
    Fairchild, R.S.; Kynder, J.L.; Abdou, N.I.: Specific immunoregulation abnormality in insulin-dependent diabetes mellitus. J. Lab. clin. Med.99: 175–186 (1982).PubMedGoogle Scholar
  75. 75.
    Galluzzo, A.; Giordano, C; Sparacino, G.; Bom-piani, G.D.; McNally, J.; Bottazzo, G.F.: Studies on suppressor cell function in the families of patients with insulin dependent diabetes mellitus (Abstract). Diabetologia21: 82 (1981).Google Scholar
  76. 76.
    Jaworski, M.A.; Guttman, R.D.; Colle, E.: Familial abnormalities of suppressor T cell activity in juvenile-onset insulin-dependent diabetes mellitus (Abstract). Clin. Res.30: 395 (1982).Google Scholar
  77. 77.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Suppressor cell activity and beta-cell function in insulin-dependent diabetes. Acta pathol. microbiol. scand., C, Immunol.90: 53–57 (1982).Google Scholar
  78. 78.
    Buschard, K.; Madsbad, S.; Krarup, T.; Rygaard, J.: Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus. Clin. exp. Immunol.48: 189–195 (1982).PubMedGoogle Scholar
  79. 79.
    Lederman, M.M.; Ellner, J.J.; Rodman, H.M.: Defective suppressor cell generation in juvenile onset diabetes. J. Immun.127: 2051–2055 (1981).PubMedGoogle Scholar
  80. 80.
    Serjeantson, S.; Theophilus, J.; Zimmet, P.; Court, J.; Crossley, J.R.; Elliott, R.B.: Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus. Diabetes30: 26–29 (1981).PubMedCrossRefGoogle Scholar
  81. 81.
    Sakane, T.; Steinberg, A.D.; Reeves, J.P.; Green, I.: Studies of immune functions of patients with systemic lupus erythematosus. J. clin. Invest.64: 1260–1269(1978).CrossRefGoogle Scholar
  82. 82.
    Srikanta, S.; Ganda, O.; Soeldner, S.; Eisenbarth, G.: Unpublished observations.Google Scholar
  83. 83.
    Gorsuch, A.N.; Spencer, K.M.; Lister, J.; McNally, J.M.; Dean, B.M.; Bottazzo, G.F.; Cudworth, A.G.: Evidence of a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancetii: 1363–1365 (1981).CrossRefGoogle Scholar
  84. 84.
    Elliott, R.B.; Crossley, J.R.; Berryman, C.C.; James, A.G.: Partial preservation of pancreatic β-cell function in children with diabetes. Lancetii: 1–4(1981).CrossRefGoogle Scholar
  85. 85.
    Deckert, T., Poulson, J.; Larsen, M.: The prognosis of insulin dependent diabetes mellitus and the importance of supervision. Acta med. scand., suppl. 624, pp. 48–53 (1979).Google Scholar

Copyright information

© Humana Press Inc. 1982

Authors and Affiliations

  • John B. Buse
    • 1
  • Richard F. Rowley
    • 1
  • George S. Eisenbarth
    • 1
  1. 1.Research DivisionJoslin Diabetes Center, Inc.Boston(USA)

Personalised recommendations